Global Diphtheria Tetanus Pertussis Vaccine Market Research Report 2024

Report ID: 1914202 | Published Date: Jan 2025 | No. of Page: 99 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Diphtheria Tetanus Pertussis Vaccine Market Overview
    1.1 Product Overview and Scope of Diphtheria Tetanus Pertussis Vaccine
    1.2 Diphtheria Tetanus Pertussis Vaccine Segment by Type
        1.2.1 Global Diphtheria Tetanus Pertussis Vaccine Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 DTwP Type
        1.2.3 DTaP Type
    1.3 Diphtheria Tetanus Pertussis Vaccine Segment by Application
        1.3.1 Global Diphtheria Tetanus Pertussis Vaccine Sales Comparison by Application: (2022-2028)
        1.3.2 Child
        1.3.3 Teenager
        1.3.4 Aldult
    1.4 Global Diphtheria Tetanus Pertussis Vaccine Market Size Estimates and Forecasts
        1.4.1 Global Diphtheria Tetanus Pertussis Vaccine Revenue 2017-2028
        1.4.2 Global Diphtheria Tetanus Pertussis Vaccine Sales 2017-2028
        1.4.3 Diphtheria Tetanus Pertussis Vaccine Market Size by Region: 2017 Versus 2021 Versus 2028
2 Diphtheria Tetanus Pertussis Vaccine Market Competition by Manufacturers
    2.1 Global Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Diphtheria Tetanus Pertussis Vaccine Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Diphtheria Tetanus Pertussis Vaccine Manufacturing Sites, Area Served, Product Type
    2.5 Diphtheria Tetanus Pertussis Vaccine Market Competitive Situation and Trends
        2.5.1 Diphtheria Tetanus Pertussis Vaccine Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Diphtheria Tetanus Pertussis Vaccine Players Market Share by Revenue
        2.5.3 Global Diphtheria Tetanus Pertussis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Diphtheria Tetanus Pertussis Vaccine Retrospective Market Scenario by Region
    3.1 Global Diphtheria Tetanus Pertussis Vaccine Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Diphtheria Tetanus Pertussis Vaccine Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Diphtheria Tetanus Pertussis Vaccine Market Facts & Figures by Country
        3.3.1 North America Diphtheria Tetanus Pertussis Vaccine Sales by Country
        3.3.2 North America Diphtheria Tetanus Pertussis Vaccine Revenue by Country
        3.3.3 United States
        3.3.4 Canada
    3.4 Europe Diphtheria Tetanus Pertussis Vaccine Market Facts & Figures by Country
        3.4.1 Europe Diphtheria Tetanus Pertussis Vaccine Sales by Country
        3.4.2 Europe Diphtheria Tetanus Pertussis Vaccine Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Diphtheria Tetanus Pertussis Vaccine Market Facts & Figures by Region
        3.5.1 Asia Pacific Diphtheria Tetanus Pertussis Vaccine Sales by Region
        3.5.2 Asia Pacific Diphtheria Tetanus Pertussis Vaccine Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 China Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
    3.6 Latin America Diphtheria Tetanus Pertussis Vaccine Market Facts & Figures by Country
        3.6.1 Latin America Diphtheria Tetanus Pertussis Vaccine Sales by Country
        3.6.2 Latin America Diphtheria Tetanus Pertussis Vaccine Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Diphtheria Tetanus Pertussis Vaccine Market Facts & Figures by Country
        3.7.1 Middle East and Africa Diphtheria Tetanus Pertussis Vaccine Sales by Country
        3.7.2 Middle East and Africa Diphtheria Tetanus Pertussis Vaccine Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Diphtheria Tetanus Pertussis Vaccine Historic Market Analysis by Type
    4.1 Global Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Type (2017-2022)
    4.2 Global Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by Type (2017-2022)
    4.3 Global Diphtheria Tetanus Pertussis Vaccine Price by Type (2017-2022)
5 Global Diphtheria Tetanus Pertussis Vaccine Historic Market Analysis by Application
    5.1 Global Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Application (2017-2022)
    5.2 Global Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by Application (2017-2022)
    5.3 Global Diphtheria Tetanus Pertussis Vaccine Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Sanofi Pasteur
        6.1.1 Sanofi Pasteur Corporation Information
        6.1.2 Sanofi Pasteur Description and Business Overview
        6.1.3 Sanofi Pasteur Diphtheria Tetanus Pertussis Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Sanofi Pasteur Diphtheria Tetanus Pertussis Vaccine Product Portfolio
        6.1.5 Sanofi Pasteur Recent Developments/Updates
    6.2 GSK
        6.2.1 GSK Corporation Information
        6.2.2 GSK Description and Business Overview
        6.2.3 GSK Diphtheria Tetanus Pertussis Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 GSK Diphtheria Tetanus Pertussis Vaccine Product Portfolio
        6.2.5 GSK Recent Developments/Updates
    6.3 AJ Vaccines
        6.3.1 AJ Vaccines Corporation Information
        6.3.2 AJ Vaccines Description and Business Overview
        6.3.3 AJ Vaccines Diphtheria Tetanus Pertussis Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 AJ Vaccines Diphtheria Tetanus Pertussis Vaccine Product Portfolio
        6.3.5 AJ Vaccines Recent Developments/Updates
    6.4 KM Biologics (Meiji)
        6.4.1 KM Biologics (Meiji) Corporation Information
        6.4.2 KM Biologics (Meiji) Description and Business Overview
        6.4.3 KM Biologics (Meiji) Diphtheria Tetanus Pertussis Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 KM Biologics (Meiji) Diphtheria Tetanus Pertussis Vaccine Product Portfolio
        6.4.5 KM Biologics (Meiji) Recent Developments/Updates
    6.5 MCM Vaccine
        6.5.1 MCM Vaccine Corporation Information
        6.5.2 MCM Vaccine Description and Business Overview
        6.5.3 MCM Vaccine Diphtheria Tetanus Pertussis Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 MCM Vaccine Diphtheria Tetanus Pertussis Vaccine Product Portfolio
        6.5.5 MCM Vaccine Recent Developments/Updates
    6.6 Merck
        6.6.1 Merck Corporation Information
        6.6.2 Merck Description and Business Overview
        6.6.3 Merck Diphtheria Tetanus Pertussis Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 Merck Diphtheria Tetanus Pertussis Vaccine Product Portfolio
        6.6.5 Merck Recent Developments/Updates
    6.7 MassBiologics
        6.6.1 MassBiologics Corporation Information
        6.6.2 MassBiologics Description and Business Overview
        6.6.3 MassBiologics Diphtheria Tetanus Pertussis Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 MassBiologics Diphtheria Tetanus Pertussis Vaccine Product Portfolio
        6.7.5 MassBiologics Recent Developments/Updates
    6.8 Bionet-Asia
        6.8.1 Bionet-Asia Corporation Information
        6.8.2 Bionet-Asia Description and Business Overview
        6.8.3 Bionet-Asia Diphtheria Tetanus Pertussis Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 Bionet-Asia Diphtheria Tetanus Pertussis Vaccine Product Portfolio
        6.8.5 Bionet-Asia Recent Developments/Updates
    6.9 Amson Vaccines & Pharma
        6.9.1 Amson Vaccines & Pharma Corporation Information
        6.9.2 Amson Vaccines & Pharma Description and Business Overview
        6.9.3 Amson Vaccines & Pharma Diphtheria Tetanus Pertussis Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 Amson Vaccines & Pharma Diphtheria Tetanus Pertussis Vaccine Product Portfolio
        6.9.5 Amson Vaccines & Pharma Recent Developments/Updates
    6.10 Serum Institute of India
        6.10.1 Serum Institute of India Corporation Information
        6.10.2 Serum Institute of India Description and Business Overview
        6.10.3 Serum Institute of India Diphtheria Tetanus Pertussis Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.10.4 Serum Institute of India Diphtheria Tetanus Pertussis Vaccine Product Portfolio
        6.10.5 Serum Institute of India Recent Developments/Updates
    6.11 Panacea Biotec
        6.11.1 Panacea Biotec Corporation Information
        6.11.2 Panacea Biotec Diphtheria Tetanus Pertussis Vaccine Description and Business Overview
        6.11.3 Panacea Biotec Diphtheria Tetanus Pertussis Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.11.4 Panacea Biotec Diphtheria Tetanus Pertussis Vaccine Product Portfolio
        6.11.5 Panacea Biotec Recent Developments/Updates
    6.12 BioKangtai
        6.12.1 BioKangtai Corporation Information
        6.12.2 BioKangtai Diphtheria Tetanus Pertussis Vaccine Description and Business Overview
        6.12.3 BioKangtai Diphtheria Tetanus Pertussis Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.12.4 BioKangtai Diphtheria Tetanus Pertussis Vaccine Product Portfolio
        6.12.5 BioKangtai Recent Developments/Updates
    6.13 China National Biotec
        6.13.1 China National Biotec Corporation Information
        6.13.2 China National Biotec Diphtheria Tetanus Pertussis Vaccine Description and Business Overview
        6.13.3 China National Biotec Diphtheria Tetanus Pertussis Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.13.4 China National Biotec Diphtheria Tetanus Pertussis Vaccine Product Portfolio
        6.13.5 China National Biotec Recent Developments/Updates
    6.14 Chengdu Oulin Biological Science&Technology
        6.14.1 Chengdu Oulin Biological Science&Technology Corporation Information
        6.14.2 Chengdu Oulin Biological Science&Technology Diphtheria Tetanus Pertussis Vaccine Description and Business Overview
        6.14.3 Chengdu Oulin Biological Science&Technology Diphtheria Tetanus Pertussis Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.14.4 Chengdu Oulin Biological Science&Technology Diphtheria Tetanus Pertussis Vaccine Product Portfolio
        6.14.5 Chengdu Oulin Biological Science&Technology Recent Developments/Updates
7 Diphtheria Tetanus Pertussis Vaccine Manufacturing Cost Analysis
    7.1 Diphtheria Tetanus Pertussis Vaccine Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Diphtheria Tetanus Pertussis Vaccine
    7.4 Diphtheria Tetanus Pertussis Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Diphtheria Tetanus Pertussis Vaccine Distributors List
    8.3 Diphtheria Tetanus Pertussis Vaccine Customers
9 Diphtheria Tetanus Pertussis Vaccine Market Dynamics
    9.1 Diphtheria Tetanus Pertussis Vaccine Industry Trends
    9.2 Diphtheria Tetanus Pertussis Vaccine Market Drivers
    9.3 Diphtheria Tetanus Pertussis Vaccine Market Challenges
    9.4 Diphtheria Tetanus Pertussis Vaccine Market Restraints
10 Global Market Forecast
    10.1 Diphtheria Tetanus Pertussis Vaccine Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Diphtheria Tetanus Pertussis Vaccine by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Diphtheria Tetanus Pertussis Vaccine by Type (2023-2028)
    10.2 Diphtheria Tetanus Pertussis Vaccine Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Diphtheria Tetanus Pertussis Vaccine by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Diphtheria Tetanus Pertussis Vaccine by Application (2023-2028)
    10.3 Diphtheria Tetanus Pertussis Vaccine Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Diphtheria Tetanus Pertussis Vaccine by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Diphtheria Tetanus Pertussis Vaccine by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Diphtheria Tetanus Pertussis Vaccine Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Diphtheria Tetanus Pertussis Vaccine Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Diphtheria Tetanus Pertussis Vaccine Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Diphtheria Tetanus Pertussis Vaccine Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Diphtheria Tetanus Pertussis Vaccine Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Diphtheria Tetanus Pertussis Vaccine Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Diphtheria Tetanus Pertussis Vaccine Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Diphtheria Tetanus Pertussis Vaccine Average Price (US$/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Diphtheria Tetanus Pertussis Vaccine Manufacturing Sites and Area Served
    Table 11. Manufacturers Diphtheria Tetanus Pertussis Vaccine Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Diphtheria Tetanus Pertussis Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diphtheria Tetanus Pertussis Vaccine as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Diphtheria Tetanus Pertussis Vaccine Sales by Region (2017-2022) & (K Units)
    Table 16. Global Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Region (2017-2022)
    Table 17. Global Diphtheria Tetanus Pertussis Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by Region (2017-2022)
    Table 19. North America Diphtheria Tetanus Pertussis Vaccine Sales by Country (2017-2022) & (K Units)
    Table 20. North America Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Country (2017-2022)
    Table 21. North America Diphtheria Tetanus Pertussis Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by Country (2017-2022)
    Table 23. Europe Diphtheria Tetanus Pertussis Vaccine Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Country (2017-2022)
    Table 25. Europe Diphtheria Tetanus Pertussis Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Diphtheria Tetanus Pertussis Vaccine Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Diphtheria Tetanus Pertussis Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Diphtheria Tetanus Pertussis Vaccine Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Country (2017-2022)
    Table 33. Latin America Diphtheria Tetanus Pertussis Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Diphtheria Tetanus Pertussis Vaccine Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Diphtheria Tetanus Pertussis Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by Country (2017-2022)
    Table 39. Global Diphtheria Tetanus Pertussis Vaccine Sales by Type (2017-2022) & (K Units)
    Table 40. Global Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Type (2017-2022)
    Table 41. Global Diphtheria Tetanus Pertussis Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Diphtheria Tetanus Pertussis Vaccine Revenue Share by Type (2017-2022)
    Table 43. Global Diphtheria Tetanus Pertussis Vaccine Price by Type (2017-2022) & (US$/Unit)
    Table 44. Global Diphtheria Tetanus Pertussis Vaccine Sales (K Units) by Application (2017-2022)
    Table 45. Global Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Application (2017-2022)
    Table 46. Global Diphtheria Tetanus Pertussis Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Diphtheria Tetanus Pertussis Vaccine Revenue Share by Application (2017-2022)
    Table 48. Global Diphtheria Tetanus Pertussis Vaccine Price by Application (2017-2022) & (US$/Unit)
    Table 49. Sanofi Pasteur Corporation Information
    Table 50. Sanofi Pasteur Description and Business Overview
    Table 51. Sanofi Pasteur Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 52. Sanofi Pasteur Diphtheria Tetanus Pertussis Vaccine Product
    Table 53. Sanofi Pasteur Recent Developments/Updates
    Table 54. GSK Corporation Information
    Table 55. GSK Description and Business Overview
    Table 56. GSK Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 57. GSK Diphtheria Tetanus Pertussis Vaccine Product
    Table 58. GSK Recent Developments/Updates
    Table 59. AJ Vaccines Corporation Information
    Table 60. AJ Vaccines Description and Business Overview
    Table 61. AJ Vaccines Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 62. AJ Vaccines Diphtheria Tetanus Pertussis Vaccine Product
    Table 63. AJ Vaccines Recent Developments/Updates
    Table 64. KM Biologics (Meiji) Corporation Information
    Table 65. KM Biologics (Meiji) Description and Business Overview
    Table 66. KM Biologics (Meiji) Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 67. KM Biologics (Meiji) Diphtheria Tetanus Pertussis Vaccine Product
    Table 68. KM Biologics (Meiji) Recent Developments/Updates
    Table 69. MCM Vaccine Corporation Information
    Table 70. MCM Vaccine Description and Business Overview
    Table 71. MCM Vaccine Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 72. MCM Vaccine Diphtheria Tetanus Pertussis Vaccine Product
    Table 73. MCM Vaccine Recent Developments/Updates
    Table 74. Merck Corporation Information
    Table 75. Merck Description and Business Overview
    Table 76. Merck Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 77. Merck Diphtheria Tetanus Pertussis Vaccine Product
    Table 78. Merck Recent Developments/Updates
    Table 79. MassBiologics Corporation Information
    Table 80. MassBiologics Description and Business Overview
    Table 81. MassBiologics Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 82. MassBiologics Diphtheria Tetanus Pertussis Vaccine Product
    Table 83. MassBiologics Recent Developments/Updates
    Table 84. Bionet-Asia Corporation Information
    Table 85. Bionet-Asia Description and Business Overview
    Table 86. Bionet-Asia Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 87. Bionet-Asia Diphtheria Tetanus Pertussis Vaccine Product
    Table 88. Bionet-Asia Recent Developments/Updates
    Table 89. Amson Vaccines & Pharma Corporation Information
    Table 90. Amson Vaccines & Pharma Description and Business Overview
    Table 91. Amson Vaccines & Pharma Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 92. Amson Vaccines & Pharma Diphtheria Tetanus Pertussis Vaccine Product
    Table 93. Amson Vaccines & Pharma Recent Developments/Updates
    Table 94. Serum Institute of India Corporation Information
    Table 95. Serum Institute of India Description and Business Overview
    Table 96. Serum Institute of India Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 97. Serum Institute of India Diphtheria Tetanus Pertussis Vaccine Product
    Table 98. Serum Institute of India Recent Developments/Updates
    Table 99. Panacea Biotec Corporation Information
    Table 100. Panacea Biotec Description and Business Overview
    Table 101. Panacea Biotec Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 102. Panacea Biotec Diphtheria Tetanus Pertussis Vaccine Product
    Table 103. Panacea Biotec Recent Developments/Updates
    Table 104. BioKangtai Corporation Information
    Table 105. BioKangtai Description and Business Overview
    Table 106. BioKangtai Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 107. BioKangtai Diphtheria Tetanus Pertussis Vaccine Product
    Table 108. BioKangtai Recent Developments/Updates
    Table 109. China National Biotec Corporation Information
    Table 110. China National Biotec Description and Business Overview
    Table 111. China National Biotec Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 112. China National Biotec Diphtheria Tetanus Pertussis Vaccine Product
    Table 113. China National Biotec Recent Developments/Updates
    Table 114. Chengdu Oulin Biological Science&Technology Corporation Information
    Table 115. Chengdu Oulin Biological Science&Technology Description and Business Overview
    Table 116. Chengdu Oulin Biological Science&Technology Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 117. Chengdu Oulin Biological Science&Technology Diphtheria Tetanus Pertussis Vaccine Product
    Table 118. Chengdu Oulin Biological Science&Technology Recent Developments/Updates
    Table 119. Production Base and Market Concentration Rate of Raw Material
    Table 120. Key Suppliers of Raw Materials
    Table 121. Diphtheria Tetanus Pertussis Vaccine Distributors List
    Table 122. Diphtheria Tetanus Pertussis Vaccine Customers List
    Table 123. Diphtheria Tetanus Pertussis Vaccine Market Trends
    Table 124. Diphtheria Tetanus Pertussis Vaccine Market Drivers
    Table 125. Diphtheria Tetanus Pertussis Vaccine Market Challenges
    Table 126. Diphtheria Tetanus Pertussis Vaccine Market Restraints
    Table 127. Global Diphtheria Tetanus Pertussis Vaccine Sales Forecast by Type (2023-2028) & (K Units)
    Table 128. Global Diphtheria Tetanus Pertussis Vaccine Sales Market Share Forecast by Type (2023-2028)
    Table 129. Global Diphtheria Tetanus Pertussis Vaccine Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 130. Global Diphtheria Tetanus Pertussis Vaccine Revenue Market Share Forecast by Type (2023-2028)
    Table 131. Global Diphtheria Tetanus Pertussis Vaccine Sales Forecast by Application (2023-2028) & (K Units)
    Table 132. Global Diphtheria Tetanus Pertussis Vaccine Sales Market Share Forecast by Application (2023-2028)
    Table 133. Global Diphtheria Tetanus Pertussis Vaccine Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 134. Global Diphtheria Tetanus Pertussis Vaccine Revenue Market Share Forecast by Application (2023-2028)
    Table 135. Global Diphtheria Tetanus Pertussis Vaccine Sales Forecast by Region (2023-2028) & (K Units)
    Table 136. Global Diphtheria Tetanus Pertussis Vaccine Sales Market Share Forecast by Region (2023-2028)
    Table 137. Global Diphtheria Tetanus Pertussis Vaccine Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 138. Global Diphtheria Tetanus Pertussis Vaccine Revenue Market Share Forecast by Region (2023-2028)
    Table 139. Research Programs/Design for This Report
    Table 140. Key Data Information from Secondary Sources
    Table 141. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Diphtheria Tetanus Pertussis Vaccine
    Figure 2. Global Diphtheria Tetanus Pertussis Vaccine Market Share by Type in 2021 & 2028
    Figure 3. DTwP Type Product Picture
    Figure 4. DTaP Type Product Picture
    Figure 5. Global Diphtheria Tetanus Pertussis Vaccine Market Share by Application in 2021 & 2028
    Figure 6. Child
    Figure 7. Teenager
    Figure 8. Aldult
    Figure 9. Global Diphtheria Tetanus Pertussis Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 10. Global Diphtheria Tetanus Pertussis Vaccine Market Size (2017-2028) & (US$ Million)
    Figure 11. Global Diphtheria Tetanus Pertussis Vaccine Sales (2017-2028) & (K Units)
    Figure 12. Diphtheria Tetanus Pertussis Vaccine Sales Share by Manufacturers in 2021
    Figure 13. Global Diphtheria Tetanus Pertussis Vaccine Revenue Share by Manufacturers in 2021
    Figure 14. The Global 5 and 10 Largest Diphtheria Tetanus Pertussis Vaccine Players: Market Share by Revenue in 2021
    Figure 15. Diphtheria Tetanus Pertussis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 16. Global Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Region (2017-2022)
    Figure 17. Global Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Region in 2021
    Figure 18. Global Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by Region (2017-2022)
    Figure 19. Global Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by Region in 2021
    Figure 20. United States Diphtheria Tetanus Pertussis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 21. Canada Diphtheria Tetanus Pertussis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 22. Germany Diphtheria Tetanus Pertussis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. France Diphtheria Tetanus Pertussis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. U.K. Diphtheria Tetanus Pertussis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. Italy Diphtheria Tetanus Pertussis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. Russia Diphtheria Tetanus Pertussis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. China Diphtheria Tetanus Pertussis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. Japan Diphtheria Tetanus Pertussis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. South Korea Diphtheria Tetanus Pertussis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. India Diphtheria Tetanus Pertussis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. Australia Diphtheria Tetanus Pertussis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. China Taiwan Diphtheria Tetanus Pertussis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Indonesia Diphtheria Tetanus Pertussis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Thailand Diphtheria Tetanus Pertussis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Malaysia Diphtheria Tetanus Pertussis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Mexico Diphtheria Tetanus Pertussis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Brazil Diphtheria Tetanus Pertussis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Argentina Diphtheria Tetanus Pertussis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Turkey Diphtheria Tetanus Pertussis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Saudi Arabia Diphtheria Tetanus Pertussis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. UAE Diphtheria Tetanus Pertussis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Sales Market Share of Diphtheria Tetanus Pertussis Vaccine by Type (2017-2022)
    Figure 43. Manufacturing Cost Structure of Diphtheria Tetanus Pertussis Vaccine
    Figure 44. Manufacturing Process Analysis of Diphtheria Tetanus Pertussis Vaccine
    Figure 45. Diphtheria Tetanus Pertussis Vaccine Industrial Chain Analysis
    Figure 46. Channels of Distribution
    Figure 47. Distributors Profiles
    Figure 48. Bottom-up and Top-down Approaches for This Report
    Figure 49. Data Triangulation
    Figure 50. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Sanofi Pasteur
GSK
AJ Vaccines
KM Biologics (Meiji)
MCM Vaccine
Merck
MassBiologics
Bionet-Asia
Amson Vaccines & Pharma
Serum Institute of India
Panacea Biotec
BioKangtai
China National Biotec
Chengdu Oulin Biological Science&Technology
Frequently Asked Questions
Diphtheria Tetanus Pertussis Vaccine report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Diphtheria Tetanus Pertussis Vaccine report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Diphtheria Tetanus Pertussis Vaccine report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports